Activated B cell type diffuse large B cell lymphoma (ABC-DLBCL), a particularly aggressive subtype of DLBCL whose pathogenesis relies on constitutively active NFκB, frequently accumulates MYD88 mutations. This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.